Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI

Biomedical Imaging and Intervention Journal

Volumn 6, Issue 2, 2010, Pages

  Lodhia, J ^a   Mandarano, G ^a   Ferris, N J ^b   Eu, P ^b   Cowell, S F ^a  

^a RMIT UNIVERSITY   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Iron oxide; Magnetic resonance imaging (MRI); Nanoparticles; Synthesis

Indexed keywords

ALCOHOL; BIOPAL; CARBOXYLIC ACID; CITRIC ACID; DENDRIMER; DEXTRAN; DIPHENYL ETHER; FERRIC OXIDE; FERRISTENE; FERUCARBOTRAN; FERUMOXSIL; LAURIC ACID; LIPOSOME; MACROGOL; MAGNETITE; MION 46; OLEIC ACID; SHU 55A; SHU 55C; SILICON DIOXIDE; SUCCIMER; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ATOMIC ABSORPTION SPECTROMETRY; BIOCOMPATIBILITY; COLLOID; CONTRAST ENHANCEMENT; DRUG COATING; DRUG SYNTHESIS; HYDROPHILICITY; JOB EXPERIENCE; LIGHT SCATTERING; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL RESEARCH; MOLECULAR IMAGING; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PARTICLE SIZE; PATIENT CARE; PRECIPITATION; PROFESSIONAL COMPETENCE; RADIATION SAFETY; RADIOLOGIST; REVERSE MICELLE; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

EID: 77957372848     PISSN: None     EISSN: 18235530     Source Type: Journal    
DOI: 10.2349/biij.6.2.e12     Document Type: Review

References (88)

1. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26(18):3995-4021.
2. Jun YW, Lee JH, Cheon J. Nanoparticle Contrast Agents for Molecular Magnetic Resonance Imaging. in: Mirkin CA, Niemeyer MC eds. Nanobiotechnology II: More Concepts and Applications. Weinheim: Wiley-VCH, 2007.
3. Lee JH, Huh YM, Jun YW, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007; 13(1):95-99.
4. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219(2):316-333.
5. Ito A, Shinkai M, Honda H et al. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005; 100(1):1-11.
6. Rochelle, Arvizo R, De M et al. Proteins and Nanoparticles: Covalent and Noncovalent Conjugates. in: Mirkin CA, Niemeyer MC eds. Nanobiotechnology II: More Concepts and Applications. Weinheim: Wiley-VCH, 2007.
7. Wang Y, Bansal V, Zelikin AN et al. Templated synthesis of single-component polymer capsules and their application in drug delivery. Nano Lett 2008; 8(6):1741-5.
8. Burda C, Chen X, Narayanan R et al. Chemistry and properties of nanocrystals of different shapes. Chem Rev 2005; 105(4):1025-102.
9. Tomlinson ID, Gussin HA, Little DM et al. Imaging GABA(c) Receptors with Ligand-Conjugated Quantum Dots. J Biomed Biotechnol 2007; 2007:76514.
10. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998; 281(5385):2016-2018.
11. Song HT, Choi JS, Huh YM, et al. Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J Am Chem Soc 2005; 127(28):9992-9993.
12. Santra S, Tapec R, Theodoropoulou N et al. Synthesis and Characterization of Silica-Coated Iron Oxide Nanoparticles in Microemulsion: The Effect of Nonionic Surfactants. Langmuir 2001; 17:2900-6.
13. Bruchez M Jr, Moronne M, Gin P et al. Semiconductor nanocrystals as fluorescent biological labels. Science 1998; 281(5385):2013-6.
14. Mulder WJ, Strijkers GJ, van Tilborg GA et al. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006; 19(1):142-64.
15. Bulte JW, de Cuyper M, Despres D et al. Short- vs. long- circulating magnetoliposomes as bone marrow-seeking MR contrast agents. J Magn Reson Imaging 1999; 9(2):329-35.
16. Nitin N, LaConte LE, Zurkiya O et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem 2004; 9(6):706-12.
17. Jung J, Matsuzaki T, Tatematsu K et al. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release 2008; 126(3):255-64.
18. Gao X, Cui Y, Levenson RM et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22(8):969-976.
19. Harris L, Goff J, Carmichael Y et al. Magnetite Nanoparticle Dispersions Stabilized with Triblock Copolymers. Chem of Mat 2003; 15:1367-77.
20. Laurent S, Forge D, Port M et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108(6):2064-110.
21. Lawaczeck RD, Menzel M, Pietsch H. Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging. Appl Organomet Chem 2004; 18:506-51.
22. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11(11):2319-31.
23. Lu ZR, Wang Y, Ye F et al. Noninvasive Visualization of In Vivo Drug Delivery of Paramagnetic Polymer Conjugates with MRI. in: Amiji MM ed. Nanotechnology for Cancer Therapy Nanotechnology. Boca Raton, FL: CRC Press Taylor & Francis Group, 2007: 201-10.
24. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007; 46(8):1222-44.
25. Morel AL, Nikitenko SI, Gionnet K et al. Sonochemical approach to the synthesis of Fe(3)O(4)@SiO(2) core-shell nanoparticles with tunable properties. ACS Nano 2008; 2(5):847-56.
26. Jun YW, Huh YM, Choi JS et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005; 127(16):5732-5733.
27. Pedro T, P MM, Sabino VV et al. Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles. in: Buschow KHJ ed. Handbook of Magnetic Materials. The Netherlands: Elsevier B V, 2006.
28. Peng X, Wickham J, Alivisatos AP. Kinetics of II-VI and III-V Colloidal Semiconductor Nanocrystal Growth: Focusing of Size Distributions. J Am Chem Soc 1998; 120(21):5343-4.
29. Boistelle R, Astier JP. Crystallization mechanisms in solution. J Crys Growth 1988; 90:14-30.
30. LaMer VK, Dinegar RH. Theory, Production and Mechanism of Formation of Monodispersed Hydrosols. J Am Chem Soc 1950; 72(11):4847-4854.
31. Den Ouden CJJ, Thompson RW. Analysis of the formation of monodisperse populations by homogeneous nucleation. J Colloid and Interface Sci 1991; 143(1):77-84.
32. Ng JD, Lorber B, Witz J et al. The crystallization of biological macromolecules from precipitates: evidence for Ostwald ripening. J Crys Growth 1996; 168(1-4):50-62.
33. Morales MP, González-Carreño T, Serna CJ. The formation of a-Fe2O3 monodispersed particles in solution. J Mat Res 1992; 7(9):2538-45.
34. Ocaña M, Rodriguez-Clemente R, Serna CJ. Uniform colloidal particles in solution: Formation mechanisms. Adv Mat 1995; 7(2):212-216.
35. Corot C, Robert P, Idee JM et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58(14):1471-504.
36. Bai X, Son SJ, Zhang S et al. Synthesis of superparamagnetic nanotubes as MRI contrast agents and for cell labeling. Nanomedicine (Lond) 2008; 3(2):163-174.
37. Thünemann A, Schütt D, Kaufner L et al. Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid). Langmuir 2006; 22:2531-2537.
38. Massart R. Preparation of Aqueous Magnetic Liquids in Alkaline and Acidic Media. IEEE Trans Magn 1981; 17:1247-1248.
39. Jolivet JP, Belleville P, Tronc E et al. Influence of Fe(II) on the formation of the spinel iron oxide in alkaline medium. Clays and Clay Minerals 1992; 40(5):531-539.
40. Babes L, Denizot B, Tanguy G et al. Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study. J Colloid Interface Sci 1999; 212(2):474-482.
41. Jiang W, Yang HC, Yang SY et al. Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J Magn and Magn Mat 2004; 283:210-214.
42. Vayssières L, Chanéac C, Tronc E et al. Size Tailoring of Magnetite Particles Formed by Aqueous Precipitation: An Example of Thermodynamic Stability of Nanometric Oxide Particles. J Colloid and Interface Sci 1998; 205(2):205-12.
43. Fauconnier N, Roger J, Pons JN. Adsorption of gluconic and citric acids on maghemite particles in aqueous medium. Prog Colloid Polym Sci 1996; 100:212-216.
44. Bee A, Massart R, Neveu S. Synthesis of very fine maghemite particles. J Magn and Magn Mat 1995; 149:6-9.
45. Fauconnier N, Pons JN, Roger J et al. Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid. J Colloid Interface Sci 1997; 194(2):427-433.
46. Lee KM, Kim SG, Kim WS et al. Properties of Iron Oxide Particles Prepared in the Presence of Dextran. Korean J Chem Eng 2002; 19:480-485.
47. Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid and Interface Sci 1968; 26(1):62-69.
48. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17(7):484-99.
49. Gobe M, Kon-No K, Kandori K et al. Preparation and characterization of monodisperse magnetite sols in W/O microemulsion. J Colloid and Interface Sci 1983; 93(1):293-295.
50. Nassar N, Husein M. Preparation of iron oxide nanoparticles from FeCl3 solid powder using microemulsions. IEEE Trans Magn 2006; 203(6):1324-1328.
51. Lee KM, Sorensen CM, Klabunde KJ et al. Synthesis and Characterization of Stable Colloidal Fe304 Particles in Water-In- Oil Microemulsions. IEEE Trans Magn 1992; 28(5):3180-3182.
52. Dresco PA, Zaitsev VS, Gambino RJ et al. Preparation and Properties of Magnetite and Polymer Magnetite Nanoparticles. Langmuir 1999; 15(6):1945-1951.
53. Lopez-Perez JA, Lopez-Quintela MA, Mira J et al. Preparation of magnetic fluids with particles obtained in microemulsions. IEEE Trans Magn 1997; 33(5):4359-4362.
54. Strable E, Bulte JWM, Moskowitz B et al. Synthesis and Characterization of Soluble Iron Oxide-Dendrimer Composites. Chem of Mat 2001; 13:2201-2209.
55. Degiorgio V. Physics of amphiphiles: micelles, vesicles and microemulsions. Amsterdam: 1985.
56. Inouye K, Endo R, Otsuka Y et al. Oxygenation of ferrous ions in reversed micelle and reversed microemulsion. J Phys Chem 1982; 86(8):1465-1469.
57. Lee Y, Lee J, Bae CJ et al. Large-Scale Synthesis of Uniform and Crystalline Magnetite Nanoparticles Using Reverse Micelles as Nanoreactors under Reflux Conditions. Adv Functional Mat 2005; 15(3):503-509.
58. Tartaj P, Serna CJ. Microemulsion-Assisted Synthesis of Tunable Superparamagnetic Composites. Chem Mater 2002; 14(10):4396-4402.
59. Wan S, Huang J, Guo M et al. Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids. J Biomed Mater Res A 2007; 80(4):946-954.
60. Acar HY, Garaas RS, Syud F et al. Superparamagnetic nanoparticles stabilized by polymerized PEGylated coatings. J Magn and Magn Mat 2005; 293(1):1-7.
61. Bulte JWM, Cuyper MD, Nejat D. Magnetoliposomes as Contrast Agents. Methods in Enzymology. Academic Press, 2003: 175-198.
62. Bulte JW, Ma LD, Magin RL et al. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 1993; 29(1):32-37.
63. De Cuyper M, Joniau M. Magnetoliposomes. Formation and structural characterization. Eur Biophys J 1988; 15(5):311-319.
64. Bulte JWM, Cuyper MD, Despres D et al. Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent. J Magn and Magn Mat 1999; 194(1-3):204-209.
65. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17(7):484-499.
66. Bulte JW, Ben-Hur T, Miller BR et al. MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn Reson Med 2003; 50(1):201-205.
67. Walter GA, Cahill KS, Huard J et al. Noninvasive monitoring of stem cell transfer for muscle disorders. Magn Reson Med 2004; 51(2):273-277.
68. Lee IH, Bulte JW, Schweinhardt P et al. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol 2004; 187(2):509-516.
69. Sun S, Zeng H. Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc 2002; 124(28):8204-8205.
70. Hyeon T, Lee SS, Park J et al. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 2001; 123(51):12798-12801.
71. Park J, An K, Hwang Y et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nano Letters 2004; 3:891-895.
72. Sahoo Y, Goodarzi A, Swihart MT et al. Aqueous ferrofluid of magnetite nanoparticles: Fluorescence labeling and magnetophoretic control. J Phys Chem B 2005; 109(9):3879-3885.
73. Huh YM, Jun YW, Song HT et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 2005; 127(35):12387-12391.
74. Sun Y, Duan L, Guo Z et al. An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application. J Magn and Magn Mat 2005; 285(1-2):65-70.
75. Sun S, Zeng H, Robinson DB et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004; 126(1):273-279.
76. Ohmori M, Matijevic E. Preparation and properties of uniform coated colloidal particles. VII. Silica on hematite. J Colloid and Interface Sci 1992; 150(2):594-598.
77. Berry CC, Wells S, Charles S et al. Cell response to dextran- derivatised iron oxide nanoparticles post internalisation. Biomaterials 2004; 25(23):5405-5413.
78. Molday RS, MacKenzie D. Immunospecific ferromagnetic iron- dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 1982; 52(3):353-367.
79. Moore A, Marecos E, Bogdanov A Jr et al. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000; 214(2):568-574.
80. Paul KG, Frigo TB, Groman JY et al. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjug Chem 2004; 15(2):394-401.
81. Kim DK, Zhang Y, Voit W et al. Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn and Magn Mat 2001; 225(1-2):30-36.
82. Thomas G, Hütten A. Characterization of nano-magnetic structures. Nanostructured Mat 1997; 9(1-8):271-280.
83. Bootz A, Vogel V, Schubert D et al. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 2004; 57(2):369-375.
84. Vitali V, Jean-François G, Bas GGL et al. Metallo-supramolecular micelles: Studies by analytical ultracentrifugation and electron microscopy. J Polym Sci A Polym Chem 2003; 41(20):3159-3168.
85. Berne BJ, Pecora R. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. Mineola, New York: Dover Publications, 2000.
86. Cornell RM. The Iron oxides: Structure, Properties, Reactions, occurrences and uses. 2nd edition. New York: Wiley-VCH, 2003.
87. Robinson JW. Undergraduate Intrstumental Analysis. 5th edition. New York: M. Dekker, 1995.
88. Hilger I, Trost R, Reichenbach JR et al. MR imaging of Her-2/neu protein using magnetic nanoparticles. Nanotechnology 2007; 18:1-8.